GL

Globe Capital Limited

An investment company providing global marketing and promotion services, focusing on UK businesses.

GCAP | Aquis Stock Exchange

Overview

Corporate Details

ISIN(s):
KYG394391158
LEI:
254900IVXZE9BBS40Z05
Country:
Cayman Islands
Address:
4 KLEANTHI MESOLOGGITI STREET, 6051 Larnaca
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Globe Capital Limited is a Cayman Islands-based investment company publicly quoted on the Aquis Stock Exchange. The company's principal activity involves the worldwide marketing and promotion of other companies, with a particular focus on entities from the United Kingdom. It operates with a global presence, maintaining offices in Hong Kong, Dubai, and the UK to facilitate its business operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 08:00
Interim Report
Globe Capital Limited - Interim Results for the six months period to 30 June 20…
English 120.4 KB
2025-06-27 17:00
Annual / Quarterly Financial Statement
Globe Capital Limited - Annual report For the year ended 31 December 2024
English 208.6 KB

Automate Your Workflow. Get a real-time feed of all Globe Capital Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Globe Capital Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Globe Capital Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.